Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 6401-6410 of 10980

Edit search filters
  1. A Study to Evaluate the Long-Term Effectives on ALS Disease Progression of BIIB067

    Jacksonville, FL, Rochester, MN

  2. An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

    Scottsdale/Phoenix, AZ

  3. The Impact of Training with Whole Body EMS

    Rochester, MN

  4. A Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate the Effects of Exercise on Fatigue in Thyroid Cancer Survivors

    Rochester, MN

  6. FT516 in Subjects With Advanced Hematologic Malignancies

    Scottsdale/Phoenix, AZ

  7. A Study of The Impact of Predictive Modeling On Time to Palliative Care Review in an Inpatient Hospital Population

    Rochester, MN

  8. Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD)

  9. A Study to Compare the Effectiveness of an Invasive Treatment Approach versus Conservative Medication Alone Strategy for Patients with Stable Ischemic Heart Disease

    Jacksonville, FL

  10. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL)

    Rochester, MN

.

Mayo Clinic Footer